An investigation of clinical and immunological events following repeated aerodigestive tract challenge infections with live Mycobacterium bovis Bacille Calmette Guérin
Open Access
- 26 July 2010
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 28 (33), 5427-5431
- https://doi.org/10.1016/j.vaccine.2010.06.005
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacyHuman Vaccines, 2009
- Boosting of Cellular Immunity against Mycobacterium tuberculosis and Modulation of Skin Cytokine Responses in Healthy Human Volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral VaccineInfection and Immunity, 2006
- BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis - reviewMemórias do Instituto Oswaldo Cruz, 2005
- Simultaneous Blocking of Human Toll-Like Receptors 2 and 4 Suppresses Myeloid Dendritic Cell Activation Induced byMycobacterium bovisBacillus Calmette-Guérin PeptidoglycanInfection and Immunity, 2003
- The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.1992
- The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.Microbiological Reviews, 1992